NIH Weekly Funding Opportunities and Policy Notices

Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R21 Clinical Trial Not Allowed)

Monday, December 16, 2019 - 10:31am

Funding Opportunity RFA-MH-20-331 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research applications to elucidate mechanisms of neuroimmune dysfunction caused by HIV-1 and to detect persistent/latent/reactivated HIV using novel imaging/neuroimaging approaches in the central nervous system in anti-retroviral therapy (ART) suppressed individuals. ?These studies may involve considerable risk but may lead to a breakthrough or to the development of novel techniques, agents, methods, measures, models, or strategies, or to the generation of pilot or feasibility data. Basic, preclinical and clinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Novel Imaging Approaches for detection of Persistent HIV and Neuroimmune dysfunction associated with HIV In the Central Nervous System (CNS) (R01 Clinical Trial Optional)

Monday, December 16, 2019 - 10:29am

Funding Opportunity RFA-MH-20-330 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research applications to elucidate mechanisms of neuroimmune dysfunction caused by HIV-1 and to detect persistent/latent/reactivated HIV using novel imaging/neuroimaging approaches in the central nervous system from anti-retroviral therapy (ART) suppressed individuals. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data should consider applying to the companion R21 announcement, RFA MH-20-331 . Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease

Monday, December 16, 2019 - 10:07am

Notice NOT-HL-19-731 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Development of Nucleic Acid-based Vaccines Against Seasonal and/or Pandemic Influenza

Monday, December 16, 2019 - 10:01am

Notice NOT-AI-20-017 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Addressing Health Disparities in NIDDK Diseases

Monday, December 16, 2019 - 9:55am

Notice NOT-DK-20-003 from the NIH Guide for Grants and Contracts

Notice of Special Interest: Administrative Supplements to Cancer Center Support Grants to Support Collaborations with the Experimental Therapeutics Clinical Trials Network (ETCTN) through the Early Drug Development Opportunity Program (EDDOP)

Monday, December 16, 2019 - 9:42am

Notice NOT-CA-20-017 from the NIH Guide for Grants and Contracts

Notice of Special Interest: Alzheimers-focused Administrative Supplements for NIH/NCI Grants that are not focused on Alzheimers Disease

Monday, December 16, 2019 - 9:41am

Notice NOT-CA-20-019 from the NIH Guide for Grants and Contracts

Improving Management of Opioids and Opioid Use Disorder (OUD) in Older Adults (R18)

Monday, December 16, 2019 - 12:24am

Funding Opportunity RFA-HS-20-001 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) seeks applications to develop, implement, evaluate, and disseminate strategies to improve the management of opioid use and opioid use disorder (OUD) in older adults in primary care settings, especially in settings with large segments of socially at-risk older adults. Applicants must propose a comprehensive plan that uses evidence-based interventions and quality improvement strategies designed to improve the management of pain, opioid use, and opioid use disorder for older adults in primary care.

Notice of NHLBI Participation in PAR-19-357 "Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)"

Friday, December 13, 2019 - 10:29am

Notice NOT-HL-19-744 from the NIH Guide for Grants and Contracts

Notice of Intent to Publish a Funding Opportunity Announcement for Enhancing Bioremediation through Innovative Materials Science Approaches

Friday, December 13, 2019 - 10:21am

Notice NOT-ES-20-007 from the NIH Guide for Grants and Contracts

Notice of Intent to Publish a Funding Opportunity Announcement Re-issuance for HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)

Friday, December 13, 2019 - 10:11am

Notice NOT-AT-20-005 from the NIH Guide for Grants and Contracts

Notice of Participation of the National Institute on Aging (NIA) in PAR-19-343 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent CT Not Allowed)

Friday, December 13, 2019 - 9:59am

Notice NOT-AG-20-009 from the NIH Guide for Grants and Contracts